From: COVID-19 infection: epidemiological, clinical, and radiological expression among adult population
All patients (n = 240) | Non-severe cases (n = 186) | Severe cases (n = 54) | P value | |
---|---|---|---|---|
Age (years) | .000 | |||
Mean ± SD (median) | 45.82 ± 16.74 (44.0) | 41.88 ± 14.55 (42.00) | 59.37 ± 16.67 (62.00) | |
Range | 18–85 | 18–75 | 20–85 | |
Age groups | .000 | |||
≥ 65 years | 36 (15.0%) | 10 (5.4%) | 26 (48.1%) | |
< 65 years | 204 (85.0%) | 176 (94.6) | 28 (51.9%) | |
Gender | .000 | |||
Male | 140 (58.3%) | 96 (51.6%) | 44 (81.5%) | |
Females | 100 (41.7%) | 90 (48.4%) | 10 (18.5%) | |
Smoking history | .006 | |||
Smoker | 116 (48.3%) | 81 (43.5 %) | 35 (64.8%) | |
Non-smoker | 124 (51.7%) | 105 (56.5%) | 19 (35.2%) | |
Source of infection | 0.67 | |||
Known source | 148 (61.7%) | 116 (62.4 %) | 32 (59.3%) | |
Unknown source | 92 (38.3 %) | 70 (37.6 %) | 22 (40.7%) | |
Body temperature | .001 | |||
≤ 38 °C | 142 (59.2%) | 122 (65.6%) | 20 (37.0%) | |
> 38–39 °C | 94 (39.2%) | 62 (33.3%) | 32 (59.3%) | |
> 39 °C | 4 (1.7%) | 2 (1.1%) | 2 (3.7%) | |
Malaise | 150 (62.5%) | 120 (64.5%) | 30 (55.6%) | 0.23 |
Bone ache/myalgia | 142 (59.2%) | 104 (55.9%) | 38 (70.4%) | 0.06 |
Loss of taste/smell | 94 (39.2%) | 92 (49.5%) | 2 (3.7%) | .000 |
Headache | 76 (31.7%) | 68 (36.6%) | 8 (14.8%) | 0.002 |
Sore throat | 102 (42.5%) | 96 (51.6%) | 6 (11.1%) | .000 |
Runny nose | 86 (35.8%) | 86 (46.2%) | 0 (0.0%) | .000 |
Dry cough | 202 (84.2%) | 164 (88.2%) | 38 (70.4%) | 0.002 |
Dyspnea | 106 (44.2%) | 58 (31.2%) | 48 (88.9%) | .000 |
Chest tightness | 176 (73.3%) | 130 (69.9%) | 46 (85.2%) | 0.02 |
Chest pain | 4 (1.7%) | 0 (0.0%) | 4 (7.4%) | .000 |
Expectoration | 38 (15.8%) | 16 (8.6%) | 22 (40.7%) | .000 |
Abdominal pain | 86 (35.8%) | 74 (39.8%) | 12 (22.2%) | .01 |
Diarrhea | 70 (29.2%) 170 (70.8%) | 62 (33.3%) 124 (66.7%) | 8 (14.8%) 46 (85.2%) | .008 |
Cardiovascular diseases | 6 (2.5%) | 4 (2.2%) | 2 (3.7%) | .52 |
Cerebrovascular disorders | 4 (1.7%) | 0 (0.0%) | 4 (7.4%) | .000 |
HTN | 54 (22.5%) | 30 (16.1%) | 24 (44.4%) | .000 |
DM | 92 (38.3%) | 66 (35.5%) | 26 (48.1%) | .09 |
Other diseases | 32 (13.3%) | 30 (16.1%) | 2 (3.7%) | .01 |
O2 saturation | .000 | |||
Mean ± SD | 92.43 ± 8.48 | 96.01 ± 3.44 | 80.07 ± 9.11 | |
≤ 93 | 82 (34.2%) | 32 (17.2%) | 50 (92.6%) | |
> 93 | 158 (65.8%) | 154 (82.8%) | 4 (7.4%) | |
ICU admission | 48 (20.0%) | 8 (4.3%) | 40 (74.1%) | .000 |
Disease outcome | .000 | |||
Improvement | 212 (88.3%) | 186 (100%) | 26 (48.1%) | |
Death | 28 (11.7%) | 0 (0.0%) | 28 (51.9%) |